1. Kovacs K, Scheithauer BW, Horvath E, et al. The world health organization classification of adenohypophyseal neoplasms. Cancer 1996;78:502-510
2. Clayton RN, Wass JA. Pituitary tumours: recommendations for service provision and guidelines for management of patients. Summary of a consensus statement of a working party from the Endocrinology and Diabetes Committee of the Royal College of Physicians and the Society for Endocrinology in conjunction with the Research Unit of the Royal College of Physicians. JR Coll Physicians Lond. 1997;31:628-636
3. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol 1994;41:359-364.
4. Tjeerdsma G, Sluiter WJ, Hew JM, et al. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma. Eur J Endocrinol 1996;135:299-308.
5. Comtois R, Beauregard H, Somma M, et al. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 1991;68:860-866.
6. Turner HE, Stratton IM, Byrne JV, et al. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation – a follow-up study. Clin Endocrinol 1999;51:281-284.
7. Plowman PN. Pituitary adenoma radiotherapy – when, who and how? Clin Endocrinol 1999;51:265-271.
8. Gittoes NJL, Bates AS, Tse W, et al. Radiotherapy for non-functioning pituitary tumours.
Clin Endocrinol 1998;48:331-337.
9. Bradley KM, Adams CBT, Potter CPS, et al. An audit of selected patients with non-functioning pituitary adenoma treated by trans-sphenoidal surgery without irradiation. Clin Endocrinol 1994;41:655-659.
10. Al-Mefty O, Kersh JE, Routh A, et al. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-512.
11. McCord MW, Buatti JM, Fennell EM, et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997;39:437-444.
12. Aristizabal S, Caldwell WL, Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Rad Oncol Biol Phys 1977;2:667-673.
13. Bloom B, Kramer S. Conventional radiation therapy in the management of acromegaly.In: McL.Black P. Zervas NT, Ridgway EC, et al., editors. Secretory Tumors of the Pituitary Gland (Progress in Endocrinology Research and Therapy). New York: Raven Press, 1984: 179-190.
14. Atkinson AB, Allen IV, Gordon DS, et al. Progressive visual failure in acromegaly following external pituirary irradiation. Clin Endocrinol 1979;10:469-479.
15. Hammer HM. Optic Chiasmal Radionecrosis. Trans ophthal Soc U K 1983;103:208-211.
16. Dowsett RJ, Fowble B, Sergott RC, et al. Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys 1990;19:453-459.
17. Eastman RC, Gordon P., Glatstein E, et al. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 1992;21:693-712.
18. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology 1985;92:1118-1126.
19. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiation Oncology Biol Phys 1994;30:755-764.
20. Allisy, A. International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting photon beam therapy. ICRU Report 50; Bethesda, MD:ICRU;1993
21. Guy J, Mancuso A, Beck R, et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg 1991;74:426-432.
22. Fitzgerald CR, Enoch JM, Temme LA. Radiation therapy in and about the retina, optic nerve, and anterior visual pathway. Arch Ophthalmol 1981;99:611-623.
23. van den Bergh ACM, Dullaart RPF, Hoving MA, et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Radiother Oncol 2003;68 :95-100.
24. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 1976;120:167-171.
25. Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology 1986;93:1083-1088.
26. McCollough WM, Marcus RB, Rhoton AL, et al. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500cGy. Int J Radiat Oncol Biol Phys 1991;21:607-614.
27. Colby MY, Kearns TP. Radiation therapy of pituitary adenomas with associated visual impairment. Mayo Clin Proc 1962;37:15-24.
28. Emmanuel IG. Symposium on Pituitary tumours. 3. Historical aspects of radiotherapy, present treatment technique and results. Clin Radiol 1966;17:154-160.
29. Chang CH, Pool JL. The radiotherapy of pituitary chromophobe adenomas:an evaluation of indication, technique, and result. Radiology 1967;89:1005-1016.
30. Carlson DH, Marsh SH. Cobalt-60 teletherapy of pituitary adenomas. Radiology 1971;98:655-659.
31. Arumugasamy N, Lestina FA, Bucy PC. Treatment of pituitary adenomas: a study of 66 cases. Med J Malaya 1971;26 :3-14.
32. Hayes TP, Davis RA, Raventos A. The treatment of pituitary chromophobe adenomas. Radiology 1971;98:149-153.
33. Pistenma DA, Goffinet DR, Bagshaw MA, et al. Treatment of chromophobe adenomas with megavoltage irradiation. Cancer 1975;35:1574-1582.

34. Sheline GE, Wara WM. Radiation therapy of acromegaly and non-secretory chromophobe adenomas of the pituitary. In: Seydel HG, editor. Tumors of the nervous system. New York: John Wiley&Sons, 1975: 119-31.
35. Kramer S. Treatment of pituitary tumors by radiation therapy. In: Seydel HG, editor. Tumors of the nervous system. New York: John Wiley&Sons; 1975: 93-102.
36. Erlichman C, Meakin JW, Simpson WJ. Review of 154 patients with non-functioning pituitary tumors. Int J Radiat Oncol Biol Phys 1979;5:1981-1986.
37. Symon L, Jakubowski J. Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry 1979;42:123-133.
38. Ebersold MJ, Quast LM, Laws ER, et al. Long-term results in trans-sphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986;64:713-719.
39. Vlahovitch B, Reynaud C, Rhiati J, et al. Treatment and recurrences in 135 pituitary adenomas. Acta Neurochir Suppl 1988;42:120-123.
40. Flickinger JC, Nelson PB, Martinez AJ, et al. Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 1989;63:2409-2414.
41. Tran LM, Blount L, Horton D, et al. Radiation Therapy of Pituitary Tumors: Results in 95 Cases. Am J Clin Oncol 1991;14:25-29.
42. Grattan-Smith PJ, Morris JG, Langlands AO. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psychiatry 1992;55:949-955.
43. Salinger DJ, Brady LW, Miyamoto CT. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol 1992;15:467-473.
44. Zaugg M, Adaman O, Pescia R, et al. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-50 Gy. Int J Radiat Oncol Biol Phys 1995;32:671-680.
45. Cornett MS, Paris KJ, Spanos WJ, et al. Radiation therapy for pituitary adenomas. A retrospective study of the University of Louisville experience. Am J Clin Oncol 1996;19:292-295.
46. Grabenbauer GG, Fietkau R, Buchfelder M, et al. Hormoninaktive Hypophyseadenome: Resultate und spätfolgen nach operation und radiotherapie. Strahlenther Onkol 1996;172:193-197.
47. Colao A, Cerbone G, Cappabianca P, et al. Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998;21:284-290.
48. Breen P, Flickinger JC, Kondziolka D, et al. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 1998;89:933-938.

49. Mitsumori M, Shrieve DC, Alexander E, et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998;42:573-580.
50. Sasaki R, Murakami M, Okamoto Y, et al. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 2000;47:1337-1345.
51. Isobe K, Ohta M, Yasuda S, et al. Postoperative radiation therapy for pituitary adenoma. J Neurooncol 2000;48:135-140.
52. Crompton MR, Layton Dd. Delayed radionecrosis of the brain following therapeutic X-radiation of the pituitary. Brain 1961;84:85-101.
53. Martins AN, Johnston JS, Henry JM, et al. Delayed radiation necrosis of the brain. J Neurosurg 1977; 47:336-345.
54. Lorenzo DN, Nolletti A, Palma L. Late cerebral radionecrosis. Neurosurgery 1978;10;281-290.
55. Fukamachi A, Wakao T, Akai J. Brain stem necrosis after irradiation of pituitary adenoma. Surg Neurol 1982;18:343-350.
56. Kundra SN, Sharma BS, Banerjee AK, et al. Damage to the anterior visual pathway and brain parenchyma following external pituitary irradiation. Indian J Cancer 1990;27:172-179.
57. Zimmerman CF, Schatz NJ, Glaser JS. Magnetic resonance imaging of radiation optic neuropathy. Am J Ophthalmol 1990;110:389-394.
58. Millar JL, Spry NA, Lamb DS, et al. Blindness in patients after external beam irradiation for pituitary adenomas: two cases occurring after small daily fractional doses. Clinical Oncology 1991;3:291-294.
59. Hudgins PA, Newmann NJ, Dillon WP, et al. Radiation-induced optic neuropathy: characteristic appearances on gadolinium-enhanced MR. AJNR 1992;13 ;235-238.
60. Sallet G, Kestelyn P. Radiation-induced optic neuropathy. Bull Soc belge ophtalmol 1992;243:99-107.
61. Hughes MN, Llamas KJ, Yelland ME, et al. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys 1993;27:1035-1043.
62. McClellan RL, el Gammal T, Kline LB. Early bilateral radiation-induced optic neuropathy with follow-up MRI. Neuroradiology 1995;37:131-133.